Live Chat ×
Skip to main content

MDS Non Transplant Treatments: What's in the Pipeline

Dr. Michael Keng (University of Virginia) discusses what is on the horizon for MDS non-transplant treatments. He begins with a discussion of current non transplant treatments available for low and high risk MDS patients. Next, he talks about important updates in the treatment of bone marrow failure such as the importance of genomics and emerging therapies. He also discusses a few active clinical trials in MDS, and show you how to locate them and search for open trials. Plenty of time will be left at the end of the webinar to get your questions answered.

By the end of this program, you will understand:

  • The latest research behind current non transplant treatments
  • Current clinical trials that are active for MDS
This webinar was brought to you by Celgene and Takeda.